Az Business magazine has selected the 30 companies that will be honored at the first Arizona Business Innovation Awards.
The 30 honorees were selected from a pool of hundreds of nominations and include AZBio and AZBio Members Xcellerate Biomedical Technologies.Continue reading
Tech Launch Arizona (TLA) recently launched the newly developed Student Entrepreneurial Fellowship Program. The fellows comprise a team of four qualified candidates from a diverse range of backgrounds who are eager to make the most of this rare opportunity. Over the course of their employment with TLA they will work closely with the venture development team and gain valuable experience in the startup assessment and launch process.Continue reading
On March 3, 2020, Exact Sciences Corp. (NASDAQ: EXAS) announced the completion of its acquisitions of Paradigm Diagnostics, Inc. and Viomics, Inc., two privately held companies based in Phoenix. Together, Paradigm and Viomics provide a differentiated late-stage therapy selection test and deep competencies in sequencing and biomarker discovery, extending Exact Sciences’ lab testing and research and development capabilities.Continue reading
On February 25, 2020, the FDA issued two Clinical Laboratory Improvement Amendments (CLIA) Waiver Applications related final guidance documents.
Biotech and Medtech innovators are working to find answers and provide support for people impacted by the Novel Corona Virus (COVID-19). As they work for develop and deliver solutions, get the latest on what you should know, situation updates and key information for travelers, healthcare professionals, the businesses from the Centers for Disease Control at the CDC Information Hub
Jordan Lancaster is an assistant research scientist with the Sarver Heart Center and founder of Avery Therapeutics, which aims to advance tissue-engineered therapeutics to treat heart disease and muscle injuries. He holds three U.S. patents. Lancaster’s technologies include MyCardia, which is designed to make new blood vessels and “re-muscularize” the heart, making it perform better.Continue reading
The 36-month project is a collaboration with MD Anderson Cancer Center in Houston and will advance a novel therapeutic for triple-negative breast cancer to the point of pre-IND meeting with the FDAContinue reading
Emagine Solutions Technology, an award-winning medical software device company located in Tucson, announced that it has received clearance from the U.S. Food & Drug Administration (“FDA”) to market its VistaScan mobile ultrasound platform. Continue reading
Saturday, February 29, 2020 is Rare Disease Day. At the Arizona Legislature, SB1571 , sponsored by Senator Kate Brophy McGee, would expand Arizona’s ability to screen newborns for two serious and too often deadly rare diseases, SMA and X-ALD so that they can be detected and treated early, providing there children with a better chance at healthier lives. The bill passed unanimously out of the Senate Health and Human Services Committee and is moving through the legislative process. Continue reading
This week AZBio will be in Washington, D.C. meeting with our Arizona Congressional Delegation and thanking them for their work and support in permanently repealing the Medical Device Excise Tax. AZBio will be joining medtech leaders from across the country as part of the annual AdvaMed Fly-In. Even if you are not able to be with us LIVE in Washington, D.C. you can share your thanks with your Representative and Senators electronically by clicking here. Continue reading